Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
About Health Canada
Access to Information Requests Completed - October 2010
This content was archived on June 24, 2013.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
Acronyms and Descriptions
- AER
- Adverse Reaction Report (Adverse Event)
- CCSVI
- Chronic cerebrospinal venous insufficiency
- DIN
- Drug Identification Number
- FNIH
- First Nations and Inuit Health
- MCPA
- 2-methyl-4-chlorophenoxyacetic acid
- NHPD
- Natural Health Products Directorate
- NOC
- Notice of Compliance
- NPN
- Natural Product Number
- PMRA
- Pest Management Regulatory Agency
- PRVD
- Proposed Re-evaluation Decision
- PWGSC
- Public Works and Government Services Canada
- SAP
- Special Authorization Program
- TBIPS
- Task Based Informatics Professional Services
Completed Requests
| Request # | Request text summary | Status of Completed Request |
|---|---|---|
| A-2007-00944 | All documentation related to funding, contribution agreements or grants and deliverables further to funding, contribution agreements or grants, under the auspices of the Health Promotion Fund and the Federal Tobacco Control Strategy - by Health Canada. Mar 1, 2006 to Jan 23, 2008. | Disclosed in part |
| A-2007-01062 | All comments submitted to PMRA - Health Canada in response to PRVD 2007-01 (MCPA) | Disclosed in part |
| A-2008-00088 | Expert Advisory Committee on Supervised Injection Sites. Apr 1, 2007 to Apr 17, 2008. | Disclosed in part |
| A-2008-00673 | All briefing books, including question period notes, prepared or sent to the new Minister of Health, Leona Aglukkaq, on Oct 30, 2008, appointed to that position by the Prime Minister of Canada, Stephen Harper. | Disclosed in part |
| A-2008-00786 | All documention generated by the department and minister's office related to the report by released in March 2008, into the state of the health of Canada's children. Nov 1, 2007 to Nov 24, 2008. | Disclosed in part |
| A-2009-00290 | All records related to product review of/or investigation into the November 2008 death of infant on change table attachment to Dorel playpen. Nov 1, 2008 to Mar 31, 2009. | Disclosed in part |
| A-2009-00509 | Reviewer's comments and correspondence pertaining to the safety, efficacy and labelling of Zyprexa (Olanzapine) manufactured by Eli Lilly, all adverse reaction information and any other material related to potential safety risks. Jan 13, 2005 to Jul 21, 2009. | Disclosed in part |
| A-2009-00596 | Any briefing notes regarding the outbreak of the H1N1 virus or H1N1 virus-like symptoms on First Nations communities in Manitoba created since Apr 1, 2009. | All disclosed |
| A-2009-00771 | All documents generated concerning sending body bags to First Nations or remote communities in preparation for a possible H1N1 outbreak. Mar 25, 2009 to Sep 25, 2009 | Disclosed in part |
| A-2009-00957 | All documents between Health Canada and GlaxoSmithKline (GSK) between 2000 and Nov 2009 regarding agreement to produce pandemic vaccine (Aprenrix). | Disclosed in part |
| A-2009-00984 | All documents related to the H1N1 vaccine between April-November 2009. | Disclosed in part |
| A-2009-01000 | Copy of reviewer's notes and correspondence for the product Vagifem (Estradiol), manufacturer by Novo Nordisk Canada Inc. NOC date 1999-12-10. DIN: 02241332. | Disclosed in part |
| A-2009-01102 | All documents that led to contracts H4133-071119/CY and H4133-071141/001/CY. | Disclosed in part |
| A-2009-01188 | Information regarding the product Ran-Acetaminophen 8 Hour; DIN 02283433. | Disclosed in part |
| A-2009-01239 | All documents relating to the first ten reports regarding deaths that have occurred during clinical trials in Canada. 2002 to Feb 2. 2010. | Disclosed in part |
| A-2009-01381 | Information regarding the product Imodium Caplets 2 mg (DIN 00860743) | Disclosed in part |
| A-2009-01413 | Information regarding the product Visible White Gel, NPN 80016385, by Colgate Oral Pharmaceuticals Inc. | Disclosed in part |
| A-2009-01429 | Information regarding the product Chlorophylle, NPN 80014835 by Le Naturiste and Vitaminol Inc. | Disclosed in part |
| A-2009-01433 | Information regarding the product Aubépine, NPN 80012544 by Léo Désilets - Maître Herboriste Inc. | All disclosed |
| A-2010-00060 | Information regarding the product Kleen & Dri XL (DIN 02268981) | Disclosed in part |
| A-2010-00117 | Information regarding the product Benefibre Chewable Tablets, NPN 80011670 by Novartis Consumer Health Canada Inc. | Disclosed in part |
| A-2010-00128 | Information regarding the product Aquafresh Advanced, NPN 80009652. | Disclosed in part |
| A-2010-00132 | Information regarding the product Aquafresh Sensitive, Aquafresh Advanced, Aquafresh Pro-Gentle, NPN 02052393. | Disclosed in part |
| A-2010-00163 | Information regarding the products Green + Daily DX, NPN 80011315 and Greens, NPN 8009137. | Disclosed in part |
| A-2010-00187 | Information regarding the products MINESTRIN 1/20 21, DIN 00315966 and MINESTRIN 1/20 28, DIN 00343838. | Disclosed in part |
| A-2010-00327 | Health Canada's investigation of Sleep Ease and the Evergreen Clinic. Aug 2006 to Dec 2006. | Disclosed in part |
| A-2010-00340 | Information regarding the product Gamunex (Immune Globulin Intravenous (Human)) 10%, DIN 02247724. | Disclosed in part |
| A-2010-00373 | Updated medical device database that goes from 2004 to 2009 to allow for five complete years' worth of data. Time frame: Oct 10, 2009 to Dec 31, 2009. | Disclosed in part |
| A-2010-00375 | Information regarding the product Pneumo 23. | Disclosed in part |
| A-2010-00384 | All documents by Health Canada to the Standing Joint Committee on the Scrutiny of Regulations with regards to any regulations promulgated under the Tobacco Act. Jan 1, 2010 to Jun 30, 2010. | All disclosed |
| A-2010-00385 | Information regarding the two reports that Health Canada prepared on the quality of water in building 224 and Hangar 7 at the Bagotville base. | Disclosed in part |
| A-2010-00389 | AERs filed with NHPD between 2004 to Jun 22, 2010 regarding CarTcell, NatCell, Lloyd Wright, Xtra-Cell, Comitris, Douglas Laboratories, Pure Encapsulations, NPN 11980, by Atrium Innovations Inc. and its subsidiaries. | Disclosed in part |
| A-2010-00394 | AERs filed with NHPD between 2004 to Jun 22, 2010 regarding HVL, Douglas Laboratories, Douglas Labs, NPN 10616 by Atrium Innovations Inc. and its subsidiaries. | Disclosed in part |
| A-2010-00419 | All communications between the Minister or the Deputy Minister with the Multiple Sclerosis Society of Canada and its officials and representatives on the subject of CCSVI. Sep 1, 2009 to Jun 29, 2010. | Disclosed in part |
| A-2010-00436 | Total regional funding allocation for Saskatchewan Region - FNIH; Total costs for the North Service Centre located in Prince Albert; Funding levels for the Northern Intertribal Health Authority in Prince Albert. | All disclosed |
| A-2010-00462 | Information regarding the product Methotrexate Injection USP, DINs 02182947, 02182777, 02182971, 02182955. | Disclosed in part |
| A-2010-00469 | Most recent inspection report for catering companies operating at Vancouver airport which provide in-flight meals and snacks to airlines. | Disclosed in part |
| A-2010-00473 | Information regarding Nano-sized titanium dioxide. | All exempted |
| A-2010-00489 | All records related to the 2009-2010 Cyclical Enforcement for children's jewellery. Dec 1, 2009 to Jul 7, 2010. | All disclosed |
| A-2010-00502 | All records related to March 29, 2010 recall of Garage bracelets. Jan 20, 2010 to Jul 7, 2010. | Disclosed in part |
| A-2010-00539 | For the 2009 2010 fiscal year, all documents needed to identify the costs paid by your organization for employee recognition activities and employee retirements. | All disclosed |
| A-2010-00599 | Original product monograph(s) for CARDENE (NICARDIPINE HYDROCHLORIDE) circa 1991. DIN 02143348 and DIN 02162733 manufactured by Hoffman-LaRoche. | All exempted |
| A-2010-00638 | Information regarding employee's fitness for duty. Fiscal Year 2008-09 and 2009-10. | All disclosed |
| A-2010-00643 | The file/dossier number for the request submitted to the Ontario office regarding the alleged non-compliant torches that were being sold in stores in Ontario and Quebec. | All disclosed |
| A-2010-00644 | Confirmation if Health Canada has issued/received NPN and/or DIN Notification Form(s) for sunscreen(s) containing nanomaterial. | All exempted |
| A-2010-00645 | AERs for the product Multaq (dronedarone). Report numbers: 000343434, 000343636, 000346194 and 000346384. | Disclosed in part |
| A-2010-00648 | AERs for the product Tecta (pantoprazole magnesium). Report numbers: 000346352, 000342526 and 000343083. | Disclosed in part |
| A-2010-00649 | AER for the product Panto IV (pantoprazole sodium). Report number: 000343063. | Disclosed in part |
| A-2010-00650 | AER for the product MIRENA. Report number: 000316239. | Disclosed in part |
| A-2010-00651 | AER for the product MAGNEVIST. Report number: 000316204. | Disclosed in part |
| A-2010-00652 | AER for the product DIANE 35. Report number: 000317200. | Disclosed in part |
| A-2010-00653 | AER for the product CIPRO XL. Report number: 000316330. | Disclosed in part |
| A-2010-00657 | Number of SAPs for Dacogen (decitabine) by Eisai Inc. Aug 28, 2010 to Sep 3, 2010. | All disclosed |
| A-2010-00661 | AERs for the product Humira. Report numbers: 000338767, 000340664, 000338737, 000339024 and 000337604. | Disclosed in part |
| A-2010-00662 | Number of SAPs for Dacogen (decitabine) by Eisai Inc. Sep 4, 2010 to Sep 10, 2010. | All disclosed |
| A-2010-00664 | Prescription Drug Claims data from Non-Insured Benefits Program. Apr 1, 2010 to Jun 30, 2010. | All disclosed |
| A-2010-00665 | AERs for the product YASMIN. Report numbers: 000344536, 000344969, 000345688 and 000346222. | Disclosed in part |
| A-2010-00667 | AERs for the product AVELOX. Report numbers: 000344681, 000345643 and 000346075. | Disclosed in part |
| A-2010-00669 | List of Access to Information requests submitted to Health Canada for the period of Aug 1-31, 2010. | Disclosed in part |
| A-2010-00678 | Information providing the number of non-insured health benefit claims received by Health Canada for 'OxyContin' for the years from 2003/2004 to 2009/2010 from 'Parhelion Medical Services Inc.' | Disclosed in part |
| A-2010-00681 | AERs for the product Cipralex. Report numbers: 000336299, 000338921, 000336112 and 000339225. | Disclosed in part |
| A-2010-00683 | AER for the product Ebixa. Report number: 000336754. | Disclosed in part |
| A-2010-00684 | AERs for the product Clopixol. Report numbers: 000336195, 000336197 and 000337127. | Disclosed in part |
| A-2010-00686 | Previously released request A-2009-00745: Information regarding the product Gen-nifedipine, DIN 02321149 by Genpharm. | Disclosed in part |
| A-2010-00687 | Previously released request A-2009-00746: Information regarding the product Gen-nifedipine, DIN 02321149 by Genpharm. | Disclosed in part |
| A-2010-00688 | Previously released request A-2009-00747: Information regarding the product Gen-nifedipine, DIN 02321149 by Genpharm and the product ADALAT XL by Bayer. | Disclosed in part |
| A-2010-00691 | Number of SAPs for Dacogen (decitabine) by Eisai Inc. Sep 11, 2010 to Sep 17, 2010. | All disclosed |
| A-2010-00701 | Information regarding the application for Medical Device License for the medical device Aloclair Mouthrinse (Device Identifiers: 2114, 4111, 2214) | Disclosed in part |
| A-2010-00703 | List of Access to Information requests closed by Health Canada for the period of Jan 1, 2009 to Sep 15, 2010 | Disclosed in part |
| A-2010-00706 | All information regarding AER for the product Coversyl Plus. Report number: 000215393. | Disclosed in part |
| A-2010-00708 | AERs for the product Coversyl 4mg. Report numbers: 000304490, 000308224, 000321572 and 000336639. | Disclosed in part |
| A-2010-00715 | Number of SAPs for Dacogen (decitabine) by Eisai Inc. Sep 18, 2010 to Sep 24, 2010. | All disclosed |
| A-2010-00721 | All information regarding the Selection Process Number: 10-NHW-CE-EA-002 | All excluded |
| A-2010-00723 | AER for the product SINGULAIR. Report numbers: 000313628. | Disclosed in part |
| A-2010-00728 | Number of SAPs for Dacogen (decitabine) by Eisai Inc. Sep 25, 2010 to Oct 1, 2010. | All disclosed |
| A-2010-00746 | Released files - A-2008-00358: Cyclical Enforcement Report 2007-08 children's jewellery, A-2008-00362: Cyclical Enforcement Novelty pencils 2007-08, A-2008-00664: 1-2-3 Countn' Fun Bath Toy, A-2008-00668: Tumble Tower by Manhattan Toy, A-2008-00669: Magnetic Blocks, A-2008-00771: 2007 Mattel toy recalls, A-2008-00773: Phthalates, A-2009-00251: Toy Committee, A-2009-01260: Recall of mood rings. | Disclosed in part |
| A-2010-00747 | Previously disclosed records on H1N1 pandemic, and body bags. | Disclosed in part |
